{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:13Z","timestamp":1791919993236,"version":"4.3.4"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003916","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T14:05:58Z","timestamp":1436882758000},"page":"e0003916","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors"],"prefix":"10.1371","volume":"9","author":[{"given":"Leandro A. A.","family":"Avelar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian D.","family":"Camilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"de Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Gon\u00e7alez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McKerrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika V. Me\u00f1aca","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean F. R.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josmar R.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Saidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Chagas C (1909) Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memorias do Instituto Oswaldo Cruz 1: 1\u201362.","DOI":"10.1590\/S0074-02761909000200008"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","article-title":"Clinical and epidemiological aspects of Chagas disease","volume":"1","author":"A Prata","year":"2001","journal-title":"The Lancet Infectious Diseases"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"A Rassi Jr.","journal-title":"The Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"\u00c1 Moncayo","year":"2009","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"ref5","first-page":"1","article-title":"Control of Chagas disease","volume":"905","year":"2002","journal-title":"World Health Organization technical report series"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nature09221","article-title":"Chagas disease: a new worldwide challenge","volume":"465","author":"JR Coura","year":"2010","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas&apos; disease (American trypanosomiasis)","volume":"25","author":"JA Castro","year":"2006","journal-title":"Human & Experimental Toxicology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects","volume":"30","author":"S Patterson","year":"2014","journal-title":"Trends in Parasitology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/lds031","article-title":"Management of trypanosomiasis and leishmaniasis","volume":"104","author":"MP Barrett","year":"2012","journal-title":"British Medical Bulletin"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches","volume":"115","author":"JA Urbina","year":"2010","journal-title":"Acta Tropica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e2866","DOI":"10.1371\/journal.pntd.0002866","article-title":"Finding New Collaboration Models for Enabling Neglected Tropical Disease Drug Discovery","volume":"8","author":"MP Pollastri","year":"2014","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1087057114552623","article-title":"A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging","volume":"20","author":"MD Lewis","year":"2015","journal-title":"Journal of Biomolecular Screening"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbapap.2011.05.011","article-title":"The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death","volume":"1824","author":"VE Alvarez","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Proteins and Proteomics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A Cysteine Protease Inhibitor Cures Chagas&apos; Disease in an Immunodeficient-Mouse Model of Infection","volume":"51","author":"PS Doyle","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.188.4.725","article-title":"Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection","volume":"188","author":"JC Engel","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0020-7519(99)00044-2","article-title":"Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action","volume":"29","author":"JH McKerrow","year":"1999","journal-title":"International Journal for Parasitology"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Martinez-Mayorga K, Byler KG, Ramirez-Hernandez AI, Terrazas-Alvares DE Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discovery Today. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.drudis.2015.02.004\" xlink:type=\"simple\">http:\/\/dx.doi.org\/10.1016\/j.drudis.2015.02.004<\/ext-link>","DOI":"10.1016\/j.drudis.2015.02.004"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.bmcl.2009.05.071","article-title":"Dipeptidyl nitrile inhibitors of Cathepsin L","volume":"19","author":"N Asaad","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1021\/jm3007257","article-title":"(1R,2R)-N-(1-Cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): A Potent and Highly Selective Cathepsin K Inhibitor for the Treatment of Osteoarthritis","volume":"55","author":"AG Dossetter","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bmcl.2007.12.047","article-title":"The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K","volume":"18","author":"JY Gauthier","year":"2008","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/anie.201006781","article-title":"Systematic Investigation of Halogen Bonding in Protein\u2013Ligand Interactions","volume":"50","author":"LA Hardegger","year":"2011","journal-title":"Angewandte Chemie International Edition"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1021\/jm050686b","article-title":"Interaction of Papain-like Cysteine Proteases with Dipeptide-Derived Nitriles","volume":"48","author":"R L\u00f6ser","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1021\/jm0301078","article-title":"A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K","volume":"46","author":"J Robichaud","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jc.2012-2972","article-title":"Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial","volume":"98","author":"K Brixen","year":"2013","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2125.2012.04471.x","article-title":"Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics\u2013results from single oral dose studies in healthy volunteers","volume":"75","author":"SA Stoch","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/jm100762r","article-title":"Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore","volume":"53","author":"FF Fleming","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.bmcl.2010.10.015","article-title":"Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease","volume":"20","author":"C Beaulieu","year":"2010","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/AAC.01855-13","article-title":"Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure","volume":"58","author":"M Ndao","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1002\/chem.201103322","article-title":"Design, Synthesis and Biological Evaluation of Potent Azadipeptide Nitrile Inhibitors and Activity-Based Probes as Promising Anti-Trypanosoma brucei Agents","volume":"18","author":"P-Y Yang","year":"2012","journal-title":"Chemistry\u2013A European Journal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1023","DOI":"10.1371\/journal.pntd.0001023","article-title":"Mining a Cathepsin Inhibitor Library for New Antiparasitic Drug Leads","volume":"5","author":"KKH Ang","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bmcl.2013.10.003","article-title":"Drug discovery considerations in the development of covalent inhibitors","volume":"24","author":"R Mah","year":"2014","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"J Singh","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"RA Copeland","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","article-title":"T cell immune responses to haptens. Structural models for allergic and autoimmune reactions","volume":"107","author":"HU Weltzien","year":"1996","journal-title":"Toxicology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e2370","DOI":"10.1371\/journal.pntd.0002370","article-title":"Non-peptidic Cruzain Inhibitors with Trypanocidal Activity Discovered by Virtual Screening and In Vitro Assay","volume":"7","author":"HJ Wiggers","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10822-013-9676-0","article-title":"Automated molecule editing in molecular design","volume":"27","author":"P Kenny","year":"2013","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/ci9000234","article-title":"Hydrogen Bonding, Electrostatic Potential, and Molecular Design","volume":"49","author":"PW Kenny","year":"2009","journal-title":"Journal of Chemical Information and Modeling"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ol300039x","article-title":"Total Synthesis of an Oxepine Natural Product, (\u00b1)-Janoxepin","volume":"14","author":"RG Doveston","year":"2012","journal-title":"Organic Letters"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1021\/bi301305k","article-title":"Mapping Inhibitor Binding Modes on an Active Cysteine Protease via Nuclear Magnetic Resonance Spectroscopy","volume":"51","author":"GM Lee","year":"2012","journal-title":"Biochemistry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1073\/pnas.0306241101","article-title":"Automated protein crystal structure determination using elves","volume":"101","author":"J Holton","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"W Kabsch","year":"2010","journal-title":"Acta Crystallographica Section D: Biological Crystallography"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"Journal of Applied Crystallography"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallographica Section D"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta Crystallographica Section D"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallographica Section D"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/j.bmcl.2013.06.029","article-title":"Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity","volume":"23","author":"FA Soares","year":"2013","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1371\/journal.pntd.0000825","article-title":"In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi","volume":"4","author":"YT Chen","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design","volume":"284","author":"ID Kerr","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.bmcl.2009.06.090","article-title":"Design of selective Cathepsin inhibitors","volume":"19","author":"PA Bethel","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/jm301119s","article-title":"Pharmacokinetic Benefits of 3,4-Dimethoxy Substitution of a Phenyl Ring and Design of Isosteres Yielding Orally Available Cathepsin K Inhibitors","volume":"55","author":"JJ Crawford","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10822-014-9757-8","article-title":"Ligand efficiency metrics considered harmful","volume":"28","author":"P Kenny","year":"2014","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","article-title":"Presenting your structures: the CCP4mg molecular-graphics software","volume":"67","author":"S McNicholas","year":"2011","journal-title":"Acta Crystallographica Section D"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc2787","article-title":"Targeting the cancer kinome through polypharmacology","volume":"10","author":"ZA Knight","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1371\/journal.pmed.0040014","article-title":"Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor","volume":"4","author":"M-H Abdulla","year":"2007","journal-title":"PLoS Medicine"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T17:51:28Z","timestamp":1540317088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003916"}},"subtitle":[],"editor":[{"given":"Michael P.","family":"Pollastri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003916","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}